[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 21, Issue 1 (5-2026) ::
2026, 21(1): 1-1 Back to browse issues page
Balancing Innovation and Equity: Intellectual Property Frameworks and Ethical Considerations in the Application of CRISPR/Cas for Developing Disease- Resistant Plants
Seyed Ali Akbar Bagherian1 , Mojahed Kamalizadeh2
1- Department of Horticultural science, College of Agriculture, Jahrom University, Jahrom, Iran. , sabagherian@gmail.com
2- Department of Agricultural Biotechnology, College of Agriculture, Jahrom University, Jahrom, Iran.
Abstract:   (20 Views)
Background: The development of CRISPR/Cas technology for the production of disease-resistant plants has great potential for ensuring food security, but it is accompanied by challenges of intellectual property rights and ethical considerations. The aim of this study was to review and analyze the intellectual property frameworks and ethical implications associated with the application of CRISPR/Cas in the production of disease-resistant plants, and to provide policy solutions to increase equitable access.
Conclusion: The results of the present study showed that; patent accumulation and lack of clarity of patent ownership limit access for researchers and farmers; ethical concerns include off-target effects, loss of genetic diversity and biopersistence. Combining coordinated licensing models (patent pools), philanthropic licenses and open ownership frameworks along with legal reforms can improve the balance between innovation and access equity.
Keywords: Genome editing, CRISPR/Cas, Intellectual property, Disease-resistant crops, Ethical considerations
Full-Text [PDF 480 kb]   (23 Downloads)    
Type of Study: Short Communication | Subject: General
Received: 2025/07/8 | Accepted: 2025/09/13 | Published: 2026/05/28
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Bagherian S A A, Kamalizadeh M. Balancing Innovation and Equity: Intellectual Property Frameworks and Ethical Considerations in the Application of CRISPR/Cas for Developing Disease- Resistant Plants. Ethics in Science and Technology 2026; 21 (1) :1-1
URL: http://ethicsjournal.ir/article-1-3476-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 21, Issue 1 (5-2026) Back to browse issues page
فصلنامه اخلاق در علوم و فناوری Ethics in Science and Technology
Creative Commons License
All works in this site are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Persian site map - English site map - Created in 0.15 seconds with 37 queries by YEKTAWEB 4741